PCI Biotech Holding
Vær den første som følger denne virksomhed
PCI Biotech Holding is a biopharmaceutical group, where most of the operations are conducted within the subsidiary PCI Biotech. The Group currently conducts operations in the development of therapeutic products based on the proprietary PCI technology. The solutions are intended for use in the treatment of cancer patients. PCI Biotech was originally founded in 2000 as a subsidiary of Photocure and is headquartered in Oslo.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
Oslo Børs
PCIB
Daglig lav / høj pris
-
Markedsværdi
-
Aktieomsætning
-
Volumen
-
Finanskalender
Generalforsamling
24.05.2024
Delårsrapport
28.08.2024
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Fondsavanse AS | 10,5 % | 10,5 % |
MP Pensjon PK | 4,3 % | 4,3 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
PCI Biotech: Invitation to second half interim 2023 results presentation
PCI Biotech initiates field testing of its proprietary technology for gene therapy manufacturing
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools